This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

29 Nov 2010

Merck KGaA Announces Extension of FDA Priority Review Period for Cladribine Tablets

Merck KGaA announced that the U.S. Food and Drug Administration has extended its review period for Cladribine Tablets.

Related News